FAB — Fusion Antibodies Share News
0.000.00%
Last trade - 00:00- £14.39m
- £14.53m
- £1.97m
Fusion Antibodies - Holding(s) in Company
Fusion Antibodies - Holding(s) in Company
Fusion Antibodies - Placing to raise approximately £1.17 million
Brief: Fusion Antibodies Says CLD Project Expected To Generate $250,000 Revenue By End Of 2025
Fusion Antibodies - Contract win
Fusion Antibodies - OptiMAL R&D Update
Fusion Antibodies - Approval of Grant Funding Application
Brief: Fusion Antibodies H1 Pretax Profit GBP -792 Thousand
Fusion Antibodies - Half-year Report
Fusion Antibodies - Director/PDMR Shareholding
Fusion Antibodies - Issue of shares to non-executive directors
Fusion Antibodies - AGM statement and trading update
Fusion Antibodies - Notice of AGM
Fusion Antibodies - Director/PDMR Shareholding
RCS - Fusion Antibodies - Investor presentation
Fusion Antibodies - Director/PDMR Shareholding
Fusion Antibodies - Final Results
RCS - Fusion Antibodies - Expansion to OptiMAL collaboration agreement
Fusion Antibodies - Director/PDMR Shareholding